CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 99 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $717,000 | +705.6% | 391,860 | +2141.0% | 0.00% | – |
Q3 2021 | $89,000 | -89.5% | 17,486 | -87.0% | 0.00% | -100.0% |
Q2 2021 | $850,000 | +8.8% | 134,285 | +32.9% | 0.00% | 0.0% |
Q1 2021 | $781,000 | -3.8% | 101,008 | -18.5% | 0.00% | 0.0% |
Q4 2020 | $812,000 | +0.1% | 123,929 | +1.6% | 0.00% | 0.0% |
Q3 2020 | $811,000 | -48.8% | 121,992 | -35.9% | 0.00% | -66.7% |
Q2 2020 | $1,585,000 | +47.3% | 190,325 | +35.6% | 0.00% | +50.0% |
Q1 2020 | $1,076,000 | -1.6% | 140,339 | +6.7% | 0.00% | +100.0% |
Q4 2019 | $1,093,000 | +171.2% | 131,558 | +140.7% | 0.00% | – |
Q3 2019 | $403,000 | -6.5% | 54,658 | +42.1% | 0.00% | – |
Q2 2019 | $431,000 | +81.1% | 38,457 | +74.0% | 0.00% | – |
Q1 2019 | $238,000 | -15.3% | 22,101 | +18.7% | 0.00% | – |
Q4 2018 | $281,000 | -53.2% | 18,619 | -42.7% | 0.00% | -100.0% |
Q3 2018 | $601,000 | -36.2% | 32,490 | -21.2% | 0.00% | 0.0% |
Q2 2018 | $942,000 | -27.6% | 41,213 | -9.8% | 0.00% | 0.0% |
Q1 2018 | $1,301,000 | -35.4% | 45,712 | -52.1% | 0.00% | -50.0% |
Q4 2017 | $2,014,000 | +110.7% | 95,387 | +81.2% | 0.00% | +100.0% |
Q3 2017 | $956,000 | +348.8% | 52,636 | +283.9% | 0.00% | – |
Q2 2017 | $213,000 | – | 13,711 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |